The growth of the market is due to growing focus on interventional radiology and nuclear medicine and rising cases of cancer demanding radiation therapy. However, organizational challenges and lack of benchmarking for dose optimization is expected to restrict the market growth during the forecast period.
Rapid advances in medical technology, device manufacturing, and imaging equipment have resulted in the refinement of original procedures with better techniques and an expansion of the indications for procedures. New techniques have been developed, and some techniques are migrated to other imaging modalities. More interventional radiological and nuclear medicine procedures are performed worldwide with high imaging efficiency. These procedures use high doses of radiation, and a longer duration may increase the risk of cancer in patients undergoing these procedures.
As reported by the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine, and 90% of radioisotope procedures are diagnostic.
Market players, such as Bayer Healthcare and Sectra Medical Systems, offer dose management software specifically for RDM in interventional imaging and nuclear medicine. Although CT applications account for a larger share of the radiation dose management market, interventional radiology and nuclear medicine applications are expected to provide significant growth opportunities in the near future.
The Asia Pacific radiation dose management market, by service or software, is segmented into radiation dose management services and radiation dose management software. The Asia Pacific radiation dose management market, by medium, is segmented into computed tomography, radiation, and mammography, fluroscopy and mammography, and other medium. Based on end user, the Asia Pacific radiation dose management market is segmented hospitals, research and medical institutes, others. Geographically, the Asia Pacific radiation dose management market can be divided into China, Japan, India, South Korea, Australia and Rest of Asia Pacific.
FUJIFILM Holdings Corporation, Bayer AG, Bracco Imaging S.p.A, GE Healthcare, Koninklijke Philips N.V., Medsquare, Novarad Corporation, Sectra AB and PACSHealth, LLC are among the leading companies operating in the Asia Pacific radiation dose management market.
Strategic insights for the Asia Pacific Radiation Dose Management provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 35.57 Million |
Market Size by 2028 | US$ 82.09 Million |
Global CAGR (2021 - 2028) | 12.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Service/Software
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
The geographic scope of the Asia Pacific Radiation Dose Management refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Asia Pacific Radiation Dose Management Market is valued at US$ 35.57 Million in 2021, it is projected to reach US$ 82.09 Million by 2028.
As per our report Asia Pacific Radiation Dose Management Market, the market size is valued at US$ 35.57 Million in 2021, projecting it to reach US$ 82.09 Million by 2028. This translates to a CAGR of approximately 12.7% during the forecast period.
The Asia Pacific Radiation Dose Management Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiation Dose Management Market report:
The Asia Pacific Radiation Dose Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Radiation Dose Management Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Radiation Dose Management Market value chain can benefit from the information contained in a comprehensive market report.